oncotomskСибирский онкологический журналSiberian journal of oncology1814-48612312-3168Tomsk National Research Medical Сепtеr of the Russian Academy of Sciences10.21294/1814-4861-2019-18-6-82-89oncotomsk-1247Research ArticleЛАБОРАТОРНЫЕ И ЭКСПЕРИМЕНТАЛЬНЫЕ ИССЛЕДОВАНИЯLABORATORY AND EXPERIMENTAL STUDIESРОЛЬ СИРТУИНА 1 В РЕГУЛЯЦИИ КЛЕТОК МЕЛАНОМЫROLE OF SIRTUIN 1 IN REGULATION OF MELANOMA CELL PROLIFERATIONhttps://orcid.org/0000-0003-0754-9955ДубовцеваИ. Ю.DubovtsevaI. Yu.

аспирант кафедры патологической физиологии им. проф. В.В. Иванова

Researcher ID (WOS): S-9831-2018

Россия, г. Красноярск, 660022, ул. Партизана Железняка, 1

Postgraduate student of the Department of Pathophysiology

Researcher ID (WOS): S-9831-2018

1, P. Zheleznyaka street, 660022, Krasnoyarsk, Russia

dubovtseva14@yandex.ruhttps://orcid.org/0000-0001-7660-700XАксененкоМ. Б.AksenenkoM. V.

кандидат медицинских наук, доцент кафедры патологической физиологии

SPIN-код: 6958-9122. Researcher ID (WOS): V-1055-2017. Author ID (Scopus): 55330015100Россия, г. Красноярск, 660022, ул. Партизана Железняка, 1

MD, PhD, Associate Professor of the Department of Pathophysiology

Researcher ID (WOS): V-1055-2017. Author ID (Scopus): 55330015100

1, P. Zheleznyaka street, 660022, Krasnoyarsk, Russia

https://orcid.org/0000-0001-8142-4283РукшаТ. Г.RukshaT. G.

доктор медицинских наук, профессор, заведующая кафедрой патологической физиологии

SPIN-код: 5412-2148. Researcher ID (WOS): A-4801-2014. Author ID (Scopus): 23009925600 Россия, г. Красноярск, 660022, ул. Партизана Железняка, 1

MD, DSc, Professor, Head of the Department of Pathophysiology

Researcher ID (WOS): A-4801-2014. Author ID (Scopus): 23009925600

1, P. Zheleznyaka street, 660022, Krasnoyarsk, Russia

tatyana_ruksha@mail.ruФГБОУ ВО «Красноярский государственный медицинский университет им. проф. В.Ф. Войно-Ясенецкого» Минздрава РоссииРоссияV.F. Voino-Yasenetsky Krasnoyarsk State Medical University of the Ministry of Health Care of the Russian FederationRussian FederationФГБОУ ВО «Красноярский государственный медицинский университет им. проф. В.Ф. Войно-Ясенецкого» Минздрава РоссииРоссияV.F. Voino-Yasenetsky Krasnoyarsk State Medical University, the Ministry of Health Care of the Russian FederationRussian Federation2019050120201868289Copyright © Дубовцева И.Ю., Аксененко М.Б., Рукша Т.Г., 20202020Дубовцева И.Ю., Аксененко М.Б., Рукша Т.Г.Dubovtseva I.Y., Aksenenko M.V., Ruksha T.G.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.siboncoj.ru/jour/article/view/1247меланомаsiRNAmiR-204-5рмикроРНКсиртуин 1гены-мишениапоптозmelanomasiRNAmiR-204-5pmiRNAsirtuin 1target genesapoptosisИсследование выполнено при поддержке Российского научного фонда (проект № 14-15-00074П).The study was supported by a grant from the Russian Science Foundation (project №14-15-00074).ReferencesМолочков В.А., Демидова Л.В. Меланоцитарные невусы и меланома кожи. М., 2012. 112 с.Molochkov V.A., Demidova L.V. Melanocytic nevi and skin melanoma. Moscow, 2012. 112 p. (in Russian).Давыдов М.И., Ганцев Ш.Х. Онкология. М., 2010. 920 с.Davydov M.I., Gantsev Sh.Kh. Oncology. Moscow, 2010. 920 p. (in Russian).Gandini S., Sera F., Cattaruzza M.S., Pasquini P., Picconi O., Boyle P., Melchi C.F. Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur J Cancer 2005; 41: 45–60. doi:10.1016/j.ejca.2004.10.016Gandini S., Sera F., Cattaruzza M.S., Pasquini P., Picconi O., Boyle P., Melchi C.F. Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur J Cancer 2005; 41: 45–60. doi:10.1016/j.ejca.2004.10.016Gandini S., Sera F., Cattaruzza M.S., Pasquini P., Picconi O., Melchi F.C., Boyle P. Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors. Eur J Cancer 2005; 40: 41–59. doi: 10.1016/j.ejca.2005.03.034.Gandini S., Sera F., Cattaruzza M.S., Pasquini P., Picconi O., Melchi F.C., Boyle P. Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors. Eur J Cancer 2005; 40: 41–59. doi: 10.1016/j.ejca.2005.03.034.Berwick M., Buller D.B., Cust A., Gallagher R., Lee T.K., Meyskens F., Pandey S., Thomas N.E., Veierød M.B., Ward S. Melanoma epidemiology and prevention. Cancer Treat Res. 2016; 167: 17–49. doi: 10.1007/978-3-319-22539-5_2.Berwick M., Buller D.B., Cust A., Gallagher R., Lee T.K., Meyskens F., Pandey S., Thomas N.E., Veierød M.B., Ward S. Melanoma epidemiology and prevention. Cancer Treat Res. 2016; 167: 17–49. doi: 10.1007/978-3-319-22539-5_2.Mihajlovic M., Vlajkovic S., Jovanovic P., Stefanovic V. Primary mucosal melanomas: acomprehensive review. Int J Clin Exp Pathol 2012; 5(8): 739–753. doi: 10.1186/s13104-015-1459-3.Mihajlovic M., Vlajkovic S., Jovanovic P., Stefanovic V. Primary mucosal melanomas: acomprehensive review. Int J Clin Exp Pathol 2012; 5(8): 739–753. doi: 10.1186/s13104-015-1459-3.Fortes C., Vries E. Nonsolar occupational risk factors for cutaneous melanoma. Int J Dermatol. 2008 Apr; 47(4): 319–28. doi: 10.1111/j.1365-4632.2008.03653.x.Fortes C., Vries E. Nonsolar occupational risk factors for cutaneous melanoma. Int J Dermatol. 2008 Apr; 47(4): 319–28. doi: 10.1111/j.1365-4632.2008.03653.x.Wang Z. MicroRNA: A matter of life or death. World J Biol Chem. 2010; 1: 41–54. doi: 10.4331/wjbc.v1.i4.41.Wang Z. MicroRNA: A matter of life or death. World J Biol Chem. 2010; 1: 41–54. doi: 10.4331/wjbc.v1.i4.41.Chen Z., Li Z., Soutto M., Wang W., Piazuelo M.B., Zhu S., Guo Y., Maturana M.J., Corvalan A.H., Chen X., Xu Z., El-Rifai W. Integrated analysis of mouse and human gastric neoplasms identifies conserved microRNA networks in gastric carcinogenesis. Gastroenterology. 2019 Mar; 156(4): 1127–1139.e8. doi: 10.1053/j.gastro.2018.11.052.Chen Z., Li Z., Soutto M., Wang W., Piazuelo M.B., Zhu S., Guo Y., Maturana M.J., Corvalan A.H., Chen X., Xu Z., El-Rifai W. Integrated analysis of mouse and human gastric neoplasms identifies conserved microRNA networks in gastric carcinogenesis. Gastroenterology. 2019 Mar; 156(4): 1127–1139.e8. doi: 10.1053/j.gastro.2018.11.052.Celano M., Rosignolo F., Maggisano V., Pecce V., Iannone M., Russo D., Bulotta S. MicroRNA-based molecular classification of papillary thyroid carcinoma. Int J Genomics. 2017; 7: 32–43. doi: 10.1155/2017/6496570.Celano M., Rosignolo F., Maggisano V., Pecce V., Iannone M., Russo D., Bulotta S. MicroRNA-based molecular classification of papillary thyroid carcinoma. Int J Genomics. 2017; 7: 32–43. doi: 10.1155/2017/6496570.Lai X., Wolkenhauer O., Vera J. Understanding microRNA- mediated gene regulatory networks through mathematical modelling. Nucleic Acids Res. 2016 Jul 27; 44(13): 601935. doi: 10.1093/nar/gkw550.Lai X., Wolkenhauer O., Vera J. Understanding microRNA- mediated gene regulatory networks through mathematical modelling. Nucleic Acids Res. 2016 Jul 27; 44(13): 601935. doi: 10.1093/nar/gkw550.Palkina N., Komina A., Aksenenko M., Moshev A., Savchenko A., Ruksha T. MiR-204 and miR-3065 exert antitumor effect on melanoma cells. Oncol Lett. 2018 Jun; 15(6): 8269–8280. doi: 10.3892/ol.2018.8443.Palkina N., Komina A., Aksenenko M., Moshev A., Savchenko A., Ruksha T. MiR-204 and miR-3065 exert antitumor effect on melanoma cells. Oncol Lett. 2018 Jun; 15(6): 8269–8280. doi: 10.3892/ol.2018.8443.Toda H., Kurozumi S., Kijima Y., Idichi T., Shinden Y., Yamada Y., Arai T., Maemura K., Fujii T., Horiguchi J., Natsugoe S., Seki N. Molecular pathogenesis of triple-negative breast cancer based on microRNA expression signatures: antitumor miR-204-5p targets AP1S3. J Hum Genet. 2018 Dec; 63(12): 1197–1210. doi: 10.1038/s10038-018-0510-3.Toda H., Kurozumi S., Kijima Y., Idichi T., Shinden Y., Yamada Y., Arai T., Maemura K., Fujii T., Horiguchi J., Natsugoe S., Seki N. Molecular pathogenesis of triple-negative breast cancer based on microRNA expression signatures: antitumor miR-204-5p targets AP1S3. J Hum Genet. 2018 Dec; 63(12): 1197–1210. doi: 10.1038/s10038-018-0510-3.Díaz-Martínez M., Benito-Jardón L., Alonso L., Koetz-Ploch L., Hernando E., Teixidó J. miR-204-5p and miR-211-5p Contribute to BRAF inhibitor resistance in melanoma. Cancer Res. 2018 Feb 15; 78(4): 1017–1030. doi: 10.1158/0008-5472.CAN-17-1318.Díaz-Martínez M., Benito-Jardón L., Alonso L., Koetz-Ploch L., Hernando E., Teixidó J. miR-204-5p and miR-211-5p Contribute to BRAF inhibitor resistance in melanoma. Cancer Res. 2018 Feb 15; 78(4): 1017–1030. doi: 10.1158/0008-5472.CAN-17-1318.Галицкий В.А. Гипотеза о механизме инициации малыми РНК метилирования ДНК de novo и аллельного исключения. Цитология. 2008; 50(4): 277–286.Halytskiy V.A. Hypothesis of the initiation of DNA methylation de novo and allelic exclusion by small RNA. Cytology. 2008; 50(4): 277–286. (in Russian).Wiking-Busch M., Ndiaye M., Liu X., Ahmad N. RNA interferencemediated knockdown of SIRT1 and/or SIRT2 in melanoma: Identification of downstream targets by large-scale proteomics analysis. J Proteomics. 2018 Jan 6; 170: 99–109. doi: 10.1016/j.jprot.2017.09.002.Wiking-Busch M., Ndiaye M., Liu X., Ahmad N. RNA interferencemediated knockdown of SIRT1 and/or SIRT2 in melanoma: Identification of downstream targets by large-scale proteomics analysis. J Proteomics. 2018 Jan 6; 170: 99–109. doi: 10.1016/j.jprot.2017.09.002.Палкина Н.В., Комина А.В., Аксененко М.Б., Белоногов Р.Н., Лаврентьев С.Н., Рукша Т.Г. Жизнеспособность клеток меланомы В16 in vitro и токсичность ингибитора miR-204-5p (LNATM) in vivo при модуляции экспрессии miR-204-5p у мышей. Цитология. 2018; 60(3): 180–187.Palkina N.V., Komina A.V., Aksenenko M.B., Belonogov R.N., Lavrentiev S.N., Ruksha T.G. Viability of melanoma B16 cells in vitro and toxicity evaluation after miR-204-5p (LNATM) inhibitor application for the miR-204-5p expression modulation in mice in vivo. Cytology. 2018; 60(3): 180–187. (in Russian).Michan S., Sinclair D. Sirtuins in mammals: insights into their biological function. Biochem J. 2007; (404): 1–13. doi: 10.1042/BJ20070140.Michan S., Sinclair D. Sirtuins in mammals: insights into their biological function. Biochem J. 2007; (404): 1–13. doi: 10.1042/BJ20070140.Chen J., Zhang B., Wong N., Lo A.W., To K.F., Chan A.W., Ng M.H., Ho C.Y., Cheng S.H., Lai P.B., Yu J., Ng H.K., Ling M.T., Huang A.L., Cai X.F., Ko B.C. Sirtuin 1 is upregulated in a subset of hepatocellular carcinomas where it is essential for telomere maintenance and tumor cell growth. Cancer Res. 2011 Jun 15; 71(12): 4138–49. doi: 10.1158/0008-5472.CAN-10-4274.Chen J., Zhang B., Wong N., Lo A.W., To K.F., Chan A.W., Ng M.H., Ho C.Y., Cheng S.H., Lai P.B., Yu J., Ng H.K., Ling M.T., Huang A.L., Cai X.F., Ko B.C. Sirtuin 1 is upregulated in a subset of hepatocellular carcinomas where it is essential for telomere maintenance and tumor cell growth. Cancer Res. 2011 Jun 15; 71(12): 4138–49. doi: 10.1158/0008-5472.CAN-10-4274.Wang F., Li H., Yan X.G., Zhou Z.W., Yi Z.G., He Z.X., Pan S.T., Yang Y.X., Wang Z.Z., Zhang X., Yang T., Qiu J.X., Zhou S.F. Alisertib induces cell cycle arrest and autophagy and suppresses epithelial- tomesenchymal transition involving PI3K/Akt/mTOR and sirtuin 1-mediated signaling pathways in human pancreatic cancer cells. Drug Des Devel Ther. 2015 Jan 17; 9: 575–601. doi: 10.2147/DDDT.S75221.Wang F., Li H., Yan X.G., Zhou Z.W., Yi Z.G., He Z.X., Pan S.T., Yang Y.X., Wang Z.Z., Zhang X., Yang T., Qiu J.X., Zhou S.F. Alisertib induces cell cycle arrest and autophagy and suppresses epithelial- tomesenchymal transition involving PI3K/Akt/mTOR and sirtuin 1-mediated signaling pathways in human pancreatic cancer cells. Drug Des Devel Ther. 2015 Jan 17; 9: 575–601. doi: 10.2147/DDDT.S75221.Grbesa I., Pajares M.J., Martínez-Terroba E., Agorreta J., Mikecin A.M., Larráyoz M., Idoate M.A., Gall-Troselj K., Pio R., Montuenga L.M. Expression of Sirtuin 1 and 2 Is associated with poor prognosis in non-small cell Lung cancer patients. PLoS One. 2010; 10 (4): e0124670. doi: 10.1371/journal.pone.0124670.Grbesa I., Pajares M.J., Martínez-Terroba E., Agorreta J., Mikecin A.M., Larráyoz M., Idoate M.A., Gall-Troselj K., Pio R., Montuenga L.M. Expression of Sirtuin 1 and 2 Is associated with poor prognosis in non-small cell Lung cancer patients. PLoS One. 2010; 10 (4): e0124670. doi: 10.1371/journal.pone.0124670.Lin Q., Mao Y., Song Y., Hyang D. MicroRNA-34a induces apoptosis in PC12 cells by reducing B-cell lymphoma 2 and sirtuin-1 expression. Mol Med Rep. 2015 Oct; 12(4): 5709–14. doi: 10.3892/mmr.2015.4185.Lin Q., Mao Y., Song Y., Hyang D. MicroRNA-34a induces apoptosis in PC12 cells by reducing B-cell lymphoma 2 and sirtuin-1 expression. Mol Med Rep. 2015 Oct; 12(4): 5709–14. doi: 10.3892/mmr.2015.4185.Gao J., Wang Y., Zhao X., Chen P., Xie L. MicroRNA-204-5pmediated regulation of SIRT1 contributes to the delay of epithelial cell cycle traversal in diabetic corneas. Invest Ophthalmol Vis Sci. 2015 Jan 22; 56(3): 1493–504. doi: 10.1167/iovs.14-15913.Gao J., Wang Y., Zhao X., Chen P., Xie L. MicroRNA-204-5pmediated regulation of SIRT1 contributes to the delay of epithelial cell cycle traversal in diabetic corneas. Invest Ophthalmol Vis Sci. 2015 Jan 22; 56(3): 1493–504. doi: 10.1167/iovs.14-15913.Liu J., Xu Y., Wu Q., Ding Q., Fan W., Liu J., Xu Y., Wu Q., Ding Q., Fan W. Sirtuin 1 protects hair follicle stem cells from TNFα-mediated inflammatory stress via activating the MAPK-ERK-Mfn2 pathway. Life Sci. 2018 1; 212: 213–224. doi: 10.1016/j.lfs.2018.10.003.Liu J., Xu Y., Wu Q., Ding Q., Fan W., Liu J., Xu Y., Wu Q., Ding Q., Fan W. Sirtuin 1 protects hair follicle stem cells from TNFα-mediated inflammatory stress via activating the MAPK-ERK-Mfn2 pathway. Life Sci. 2018 1; 212: 213–224. doi: 10.1016/j.lfs.2018.10.003.

The authors declare that there are no conflicts of interest present.